Livedoid vasculopathy in Koreans: clinical features and response to rivaroxaban treatment

J Eur Acad Dermatol Venereol. 2020 Apr;34(4):e176-e178. doi: 10.1111/jdv.16129. Epub 2020 Jan 2.

Authors

J S Lee¹, S Cho^{1

2}

Affiliations

¹ Department of Dermatology, Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul, Korea.
² Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.

PMID: 31793049
DOI: 10.1111/jdv.16129

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Child
Factor Xa Inhibitors / therapeutic use*
Female
Humans
Livedo Reticularis / drug therapy*
Male
Middle Aged
Republic of Korea
Retrospective Studies
Rivaroxaban / therapeutic use*

Substances

Factor Xa Inhibitors
Rivaroxaban